Buy this Article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Authors

  1. Aschenbrenner, Diane S. MA, RN

Abstract

* Patiromer (Veltassa), an oral suspension that binds potassium in the gastrointestinal tract, has been approved to treat hyperkalemia.

 

* Patiromer binds to many medicines, potentially decreasing their effectiveness. Thus nurses should instruct patients to take patiromer at least six hours before or after taking other medications.

 

* Because significant interactions between patiromer and sodium polystyrene sulfonate (Kayexalate) are possible, the Food and Drug Administration has required that a drug interaction study be completed by Kayexalate's manufacturer.